1571103-87-1Relevant academic research and scientific papers
SOLID FORMS OF TENAPANOR AND METHOD OF PREPARATION OF TENAPANOR
-
Page/Page column 16-17, (2019/05/30)
The invention relates to solid forms of tenapanor, in particular to crystalline form I of tenapanor free base and to solid tenapanor salts, and to methods of preparation thereof. The crystalline form I is the first known crystalline form of tenapanor. The
ELASTASE INHIBITORS
-
Paragraph 00279, (2016/01/12)
Described herein are compounds, compositions, and methods of their use for the treatment of a lung or intestinal disease.
COMPOUNDS AND METHODS FOR INHIBITING NHE-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID RETENTION OR SALT OVERLOAD AND GASTROINTESTINAL TRACT DISORDERS
-
Page/Page column 128; 129, (2014/03/25)
The present disclosure is directed to compounds and methods for the treatment of disorders associated with fluid retention or salt overload, such as heart failure (in particular, congestive heart failure), chronic kidney disease, end-stage renal disease,
